| 13.78 Data as of Jun 18 |  +0.29 / +2.15%Today’s Change | 9.37 Today|||52-Week Range 14.52 | +34.97% Year-to-Date |
| Is Elan Pushing Its Luck? Jun 18 / MotleyFool.com | Royalty Pharma Withdraws Request for Judicial Review, Announces Lapse of Offer Jun 18 / Benzinga |
| The FDA Might Pull This Drug From the Market (and Why It Doesn't Matter) Jun 18 / MotleyFool.com | Elan Advises Shareholders to Withdraw Acceptance of Royalty Offer Jun 18 / Benzinga |
| Elan Likely To Receive Higher Takeout Bids Jun 18 / MotleyFool.com | Elan Shareholder's Vote Nixes Royalty Pharma Deal Jun 17 / MotleyFool.com |
| Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target t... Jun 18 / Benzinga | Elan Explores Sale Options - Analyst Blog Jun 17 / Zacks.com |
| A Peek Into The Market Before The Trading Starts Jun 18 / Benzinga | Good News for InterMune - Analyst Blog Jun 17 / Zacks.com |
| Previous close | 13.49 |
| Today’s open | 13.69 |
| Day’s range | -- - -- |
| Volume | 24,824,333 |
| Average volume (3 months) | 10,403,814 |
| Market cap | $7.0B |
| Dividend yield | -- |
| Earnings growth (last year) | +16.02% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +26.50% |
| Revenue growth (last year) | -99.97% |
| P/E ratio | NM |
| Price/Sales | 30,253.34 |
| Price/Book | 14.42 |
| Today’s change | Today’s % change | |
|---|---|---|
| ONXXOnyx Pharmaceuticals... | -1.18 | -1.31% |
| PCYCPharmacyclics Inc | +1.07 | +1.23% |
| RDYDr.Reddy's Laborator... | -0.27 | -0.73% |
| HSPHospira Inc | +0.17 | +0.47% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $199.9K |
| Annual profit (last year) | -$97.4M |
| Net profit margin | -181,950.00% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Executive Director G. Kelly Martin |
Chief Operating Officer Hans-Peter Hasler |
Corporate headquarters Dublin, Dublin |
.
